Biotech stocks, especially of smaller companies, are notoriously risky investment exposures. Because their bread and butter is drug development, its complexity cannot be easily accounted for.
In combination with ImmunityBio’s Bacillus Calmette-Guérin vaccine, Anktiva is set to treat non-muscle invasive bladder cancer from mid-May. For investors, bladder cancer is fairly common, at an average rate of 18.2 per 100,000, with 75-80% of newly diagnosed cases classified as NMBIC. However, operating expense losses decreased from $111.9 million to $95.2 million during the period. ImmunityBio left the quarter with $133.3 million in cash, cash equivalents, and restricted cash .
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Finance Finance Latest News, Finance Finance Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
3 Smaller Tech Stocks to Buy as Focus Shifts From MegacapsStocks Analysis by The Tokenist (Timothy Fries) covering: S&P 500, Intel Corporation, NVIDIA Corporation, Advanced Micro Devices Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »
3 Small-Cap AI Stocks With Serious Growth PotentialStocks Analysis by The Tokenist (Timothy Fries) covering: S&P 500, NVIDIA Corporation, Advanced Micro Devices Inc, Innodata Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »
Apple Leads the US Buyback Resurgence, but Is it Sustainable?Stocks Analysis by The Tokenist (Timothy Fries) covering: Chevron Corp, Apple Inc, Samsung Electronics Co Ltd, Xiaomi Corp. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »
Tesla: Critical 2-Year Horizon Will Make or Break ItStocks Analysis by The Tokenist (Timothy Fries) covering: Nasdaq 100, Tesla Inc, Nio Inc Class A ADR, Li Auto Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »
Intel: A Buying Opportunity or a Lost Cause?Stocks Analysis by The Tokenist (Timothy Fries) covering: Intel Corporation, Dell Technologies Inc, Qualcomm Incorporated, Apple Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »